Vesalius Biocapital Partners
Investor profile
Venture capital
Vesalius Biocapital Partners has backed 9 European tech companies across 10 funding rounds between 2018 and 2025, joining rounds totalling €342M. Most active in Healthtech and Wellness & Beauty. Data as of Nov 2026.
Also recorded as: Vesalius Biocapital
Deals
10
distinct rounds
Companies
9
backed
Active span
2018–2025
8 yrs
Total round €
€342M
sum of rounds joined
Deals by year
distinct rounds / yearVesalius Biocapital Partners — deals by year — interactive chart.
Data table
| Vesalius Biocapital Partners — deals by year | |
|---|---|
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 1 |
Top sectors
by dealsVesalius Biocapital Partners — top sectors — interactive chart.
Data table
| Vesalius Biocapital Partners — top sectors | |
|---|---|
| Healthtech | 9 |
| Wellness & Beauty | 1 |
Stages
by dealsVesalius Biocapital Partners — stages — interactive chart.
Data table
| Vesalius Biocapital Partners — stages | |
|---|---|
| Series B | 4 |
| Series C | 3 |
| Series A | 2 |
| Other | 1 |
Countries
by dealsVesalius Biocapital Partners — countries — interactive chart.
Data table
| Vesalius Biocapital Partners — countries | |
|---|---|
| Germany | 3 |
| Belgium | 2 |
| Portugal | 2 |
| Switzerland | 2 |
| Netherlands | 1 |
Co-investment network
shared roundsCo-investment network — interactive chart.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
Frequent co-investors
shared rounds- Adjuvant Capital2
- BioMedPartners2
- Fresenius Medical Care Ventures2
- GF Group Holding2
- Swisscanto Invest2
- Verve Ventures2
- Aescuvest1
- Armilar Venture Partners1
- Beta Capital1
- BioGeneration Ventures1
- BIONIQ Capital1
- BlackRock Innovation Capital1
- Cure Capital1
- EIR Ventures1
- Forbion1
- Indico Capital Partners1
- INKEF Capital1
- Lauxera Capital Partners1
- Lince Capital1
- MTIP AG1
- Nordic Life Science1
- Optum Ventures1
- Oxford Science Enterprises1
- PFM Health Sciences1
- Pictet Alternative Advisors1
Portfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| Caresyntax | Germany | 1 | €164M |
| Memo Therapeutics | Switzerland | 2 | €61M |
| Scenic Biotech | Netherlands | 1 | €28M |
| Topas Therapeutics | Germany | 1 | €22M |
| Oncodna | Belgium | 1 | €19M |
| OMEICOS | Germany | 1 | €17M |
| Rejuvenate Boimed | Belgium | 1 | €16M |
| Nutrium | Portugal | 1 | €12M |
| tonic app | Portugal | 1 | €3.5M |
Biggest deals
top 10 by amount| Company | Stage | Amount | Date |
|---|---|---|---|
| Caresyntax | Series C | €164M | 2024-08 |
| Memo Therapeutics | Series B | €35M | 2022-02 |
| Scenic Biotech | Series A | €28M | 2022-03 |
| Memo Therapeutics | Series C | €26M | 2023-11 |
| Topas Therapeutics | Series B | €22M | 2020-10 |
| Oncodna | Series B | €19M | 2020-02 |
| OMEICOS | Series C | €17M | 2018-10 |
| Rejuvenate Boimed | Series B | €16M | 2021-10 |
| Nutrium | Series A | €12M | 2025-09 |
| tonic app | Other | €3.5M | 2019-10 |